ELAN insider transaction filings
Elanco Animal Health Inc — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-09. Screen ELAN transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 25 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 5 legs across 5 filings by 5 insiders — 63,198 shares, $1,473,069 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 21.
- Largest priced transaction: purchase of 40,000 shares @ $23.40 ($935,920) by Kurzius Lawrence Erik, filed 2026-08-21.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Kurzius Lawrence Erik — Director | 1 | 1 leg · 40,000 sh · $935,920 | — | — |
| Herendeen Paul — Director | 1 | 1 leg · 10,000 sh · $236,850 | — | — |
| Harrington Michael J — Director | 1 | 1 leg · 5,000 sh · $109,100 | — | — |
| VanHimbergen Robert M — EVP and CFO | 7 | 1 leg · 4,200 sh · $96,926 | — | 7 |
| O'Neill Shiv — GC AND CORP SEC | 1 | 1 leg · 3,998 sh · $94,273 | — | — |
| Modi Rajeev A. — SEE REMARKS | 6 | — | — | 6 |
| Simmons Jeffrey N — PRESIDENT, CEO AND DIRECTOR, Director | 6 | — | — | 6 |
| Anand Kapila K — Director | 1 | — | — | 1 |
| Kinard David S — SEE REMARKS | 1 | — | — | 1 |
Recent Form 4 filings — Elanco Animal Health Inc
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-09 | 4 | Simmons Jeffrey N — PRESIDENT, CEO AND DIRECTOR, Director | Grant/award (A): 115.38 (derivative) @ $24.50 | EDGAR |
| 2026-09-09 | 4 | Modi Rajeev A. — SEE REMARKS | Grant/award (A): 60.28 (derivative) @ $24.50 | EDGAR |
| 2026-09-09 | 4 | VanHimbergen Robert M — EVP and CFO | Grant/award (A): 8.04 (derivative) @ $24.50 | EDGAR |
| 2026-08-25 | 4 | Simmons Jeffrey N — PRESIDENT, CEO AND DIRECTOR, Director | Grant/award (A): 117.94 (derivative) @ $23.97 | EDGAR |
| 2026-08-25 | 4 | VanHimbergen Robert M — EVP and CFO | Grant/award (A): 8.22 (derivative) @ $23.97 | EDGAR |
| 2026-08-25 | 4 | Modi Rajeev A. — SEE REMARKS | Grant/award (A): 61.62 (derivative) @ $23.97 | EDGAR |
| 2026-08-21 | 4 | Kurzius Lawrence Erik — Director | Purchase (P): 40,000 @ $23.40 | EDGAR |
| 2026-08-18 | 4 | O'Neill Shiv — GC AND CORP SEC | Purchase (P): 3,998 @ $23.58 | EDGAR |
| 2026-08-13 | 4 | Harrington Michael J — Director | Purchase (P): 5,000 @ $21.82 | EDGAR |
| 2026-08-10 | 4 | Herendeen Paul — Director | Purchase (P): 10,000 @ $23.68 | EDGAR |
| 2026-08-10 | 4 | Modi Rajeev A. — SEE REMARKS | Grant/award (A): 66.77 (derivative) @ $22.12 | EDGAR |
| 2026-08-10 | 4 | VanHimbergen Robert M — EVP and CFO | Purchase (P): 4,200 @ $23.08 · Grant/award (A): 8.91 (derivative) @ $22.12 | EDGAR |
| 2026-08-10 | 4 | Simmons Jeffrey N — PRESIDENT, CEO AND DIRECTOR, Director | Grant/award (A): 127.80 (derivative) @ $22.12 | EDGAR |
| 2026-07-28 | 4 | Modi Rajeev A. — SEE REMARKS | Grant/award (A): 59.29 (derivative) @ $24.91 | EDGAR |
| 2026-07-28 | 4 | Simmons Jeffrey N — PRESIDENT, CEO AND DIRECTOR, Director | Grant/award (A): 113.49 (derivative) @ $24.91 | EDGAR |
| 2026-07-28 | 4 | VanHimbergen Robert M — EVP and CFO | Grant/award (A): 7.91 (derivative) @ $24.91 | EDGAR |
| 2026-07-14 | 4 | Modi Rajeev A. — SEE REMARKS | Grant/award (A): 59.51 (derivative) @ $24.82 | EDGAR |
| 2026-07-14 | 4 | VanHimbergen Robert M — EVP and CFO | Grant/award (A): 7.94 (derivative) @ $24.82 | EDGAR |
| 2026-07-14 | 4 | Simmons Jeffrey N — PRESIDENT, CEO AND DIRECTOR, Director | Grant/award (A): 113.90 (derivative) @ $24.82 | EDGAR |
| 2026-07-09 | 4 | VanHimbergen Robert M — EVP and CFO | Tax withholding (F): 15,336 @ $24.64 | EDGAR |
| 2026-07-02 | 4 | Kinard David S — SEE REMARKS | Grant/award (A): 25,620 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Anand Kapila K — Director | Grant/award (A): 584.11 (derivative) @ $24.61 | EDGAR |
| 2026-06-30 | 4 | Modi Rajeev A. — SEE REMARKS | Grant/award (A): 60.11 (derivative) @ $24.57 | EDGAR |
| 2026-06-30 | 4 | VanHimbergen Robert M — EVP and CFO | Grant/award (A): 8.02 (derivative) @ $24.57 | EDGAR |
| 2026-06-30 | 4 | Simmons Jeffrey N — PRESIDENT, CEO AND DIRECTOR, Director | Grant/award (A): 115.06 (derivative) @ $24.57 | EDGAR |
| 2026-06-16 | 4 | Modi Rajeev A. — SEE REMARKS | Grant/award (A): 61.11 (derivative) @ $24.17 | EDGAR |
| 2026-06-16 | 4 | VanHimbergen Robert M — EVP and CFO | Grant/award (A): 8.15 (derivative) @ $24.17 | EDGAR |
| 2026-06-16 | 4 | Simmons Jeffrey N — PRESIDENT, CEO AND DIRECTOR, Director | Grant/award (A): 116.96 (derivative) @ $24.17 | EDGAR |
| 2026-06-02 | 4 | Modi Rajeev A. — SEE REMARKS | Grant/award (A): 61.93 (derivative) @ $23.85 | EDGAR |
| 2026-06-02 | 4 | VanHimbergen Robert M — EVP and CFO | Grant/award (A): 8.26 (derivative) @ $23.85 | EDGAR |
| 2026-06-02 | 4 | Simmons Jeffrey N — PRESIDENT, CEO AND DIRECTOR, Director | Grant/award (A): 118.53 (derivative) @ $23.85 | EDGAR |
| 2026-05-26 | 4 | Ma Stacey — Director | Grant/award (A): 4,678 @ $0 · Grant/award (A): 12,196 @ $0 | EDGAR |
| 2026-05-26 | 4 | Anand Kapila K — Director | Grant/award (A): 4,678 @ $0 · Grant/award (A): 12,196 @ $0 | EDGAR |
| 2026-05-26 | 4 | Harrington Michael J — Director | Grant/award (A): 4,678 @ $0 · Grant/award (A): 12,196 @ $0 | EDGAR |
| 2026-05-26 | 4 | McDonald Kirk P — Director | Grant/award (A): 4,678 @ $0 · Grant/award (A): 12,196 @ $0 | EDGAR |
| 2026-05-26 | 4 | Kochevar Deborah Turner — Director | Grant/award (A): 4,678 @ $0 | EDGAR |
| 2026-05-26 | 4 | Herendeen Paul — Director | Grant/award (A): 4,678 @ $0 · Grant/award (A): 12,196 @ $0 | EDGAR |
| 2026-05-26 | 4 | Kurzius Lawrence Erik — Director | Grant/award (A): 4,678 @ $0 · Grant/award (A): 12,196 @ $0 | EDGAR |
| 2026-05-26 | 4 | Scots-Knight Denise — Director | Grant/award (A): 4,678 @ $0 · Grant/award (A): 12,196 @ $0 | EDGAR |
| 2026-05-26 | 4 | HOOVER R DAVID — Director | Grant/award (A): 4,678 @ $0 | EDGAR |
| 2026-05-26 | 4 | GARCIA ART A — Director | Grant/award (A): 4,678 @ $0 · Grant/award (A): 12,196 @ $0 | EDGAR |
| 2026-05-19 | 4 | Modi Rajeev A. — SEE REMARKS | Purchase (P): 4,911 @ $20.35 · Grant/award (A): 74.37 (derivative) @ $19.86 | EDGAR |
| 2026-05-19 | 4 | VanHimbergen Robert M — EVP and CFO | Grant/award (A): 9.92 (derivative) @ $19.86 | EDGAR |
| 2026-05-19 | 4 | Simmons Jeffrey N — PRESIDENT, CEO AND DIRECTOR, Director | Purchase (P): 4,971 @ $20.09 · Grant/award (A): 142.34 (derivative) @ $19.86 | EDGAR |
| 2026-05-05 | 4 | Modi Rajeev A. — SEE REMARKS | Grant/award (A): 65.61 (derivative) @ $22.51 | EDGAR |
| 2026-05-05 | 4 | VanHimbergen Robert M — EVP and CFO | Grant/award (A): 8.75 (derivative) @ $22.51 | EDGAR |
| 2026-05-05 | 4 | Simmons Jeffrey N — PRESIDENT, CEO AND DIRECTOR, Director | Grant/award (A): 125.59 (derivative) @ $22.51 | EDGAR |
| 2026-04-21 | 4 | Modi Rajeev A. — SEE REMARKS | Grant/award (A): 62.37 (derivative) @ $23.68 | EDGAR |
| 2026-04-21 | 4 | VanHimbergen Robert M — EVP and CFO | Grant/award (A): 8.32 (derivative) @ $23.68 | EDGAR |
| 2026-04-21 | 4 | Simmons Jeffrey N — PRESIDENT, CEO AND DIRECTOR, Director | Grant/award (A): 119.38 (derivative) @ $23.68 | EDGAR |
Recent 8-K events — Elanco Animal Health Inc
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-27 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-24 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-12 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-09 | 8-K | ? 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-03 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-26 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ELAN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →